Principia Biopharma Adds Even More Shares to IPO
Principia Biopharma now intends to price more than 6 million shares for an initial public offering valued up to more than $122 million.
All Work
Chris Lange
Sears Shocks in Q2 Despite Massive Loss
Sears Holdings reported its fiscal second-quarter financial results after the markets closed on Thursday. In a surprising reaction to these results, investors sent shares higher even though this retail chain is on its last…
What This FDA Approval Means for STAAR Surgical
STAAR Surgical shares made a handy gain on Friday after the firm announced a key approval by the FDA.
Allogene Therapeutics Files for IPO
Clinical-stage immuno-oncology company Allogene Therapeutics has filed with the SEC in regards to its initial public offering.
Why Dave & Buster’s Earnings Are So Great
Dave & Buster’s reported better-than-expected fiscal second-quarter financial results before the markets opened on Friday.
Thursday’s Biggest Winners and Losers in the S&P 500
Thursday was a positive day for the broad U.S. markets. Crude oil took a big step back below $70. The S&P 500 sectors were more or less split down the middle.
Why Impinj Shares Are Booming
Impinj shares soared after it released its fiscal second-quarter earnings report late on Wednesday.
Is Fitbit in Trouble With Apple’s New Watch?
Fitbit shares bounced back in Thursday’s session after posting a loss of nearly 7% on Wednesday in regards to the Apple presentation for its fall product lineup.
Can Acorda Therapeutics Get Past This FDA Move?
Acorda Therapeutics shares dipped on Thursday after the company announced that the FDA would be delaying its Prescription Drug User Fee Act goal date for its review of the New Drug Application of Inbrija.
Why Tailored Brands Is Thursday’s Big Earnings Winner
Tailored Brands shares rallied after it released its fiscal second-quarter financial results late on Wednesday.
Why Progenics Shares Are Getting Crushed
Progenics Pharmaceuticals shares dropped on Thursday after the company announced late-stage results from its prostate cancer study.
Major Oil Stocks Send Short Sellers Running for Cover
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected big oil stocks decreased.
Short Sellers Can’t Make Up Their Minds on Social Media Stocks
The August 31 short interest data have been compared with the previous report. Short interest moves in these selected social media stocks were mixed for this settlement date.
Short Sellers Back Off Major Pharma Stocks
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Is Semiconductor Short Interest Signalling an End to the Market Rally?
The August 31 short interest data have been compared with the previous report. Short interest in most of these selected semiconductor stocks increased.
Short Sellers Hike Their Bets in Cybersecurity Stocks
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected cybersecurity stocks increased.
Major Banks Scare Off Short Sellers
The August 31 short interest data have been compared with the previous figures, and short interest in most of these selected big bank stocks decreased.
Short Sellers Up the Ante in Major Biotechs
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in most of the…
Wednesday’s Biggest Winners and Losers in the S&P 500
Wednesday was a mixed day for the broad U.S. markets. Crude oil made a big move in the session and reached back above $70. The S&P 500 sectors were mostly positive.
NIO Quietly Shifts Into the US in IPO
NIO entered the market relatively quietly in its initial public offering. This company is a direct competitor of Tesla in the electric vehicle market.